Details for New Drug Application (NDA): 021958
✉ Email this page to a colleague
The generic ingredient in LAMISIL AT is terbinafine hydrochloride. There are twenty-seven drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the terbinafine hydrochloride profile page.
Summary for 021958
Tradename: | LAMISIL AT |
Applicant: | Karo Hlthcare |
Ingredient: | terbinafine |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | GEL;TOPICAL | Strength | 1% | ||||
Approval Date: | Jul 24, 2006 | TE: | RLD: | Yes |
Expired US Patents for NDA 021958
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Karo Hlthcare | LAMISIL AT | terbinafine | GEL;TOPICAL | 021958-001 | Jul 24, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Karo Hlthcare | LAMISIL AT | terbinafine | GEL;TOPICAL | 021958-001 | Jul 24, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Karo Hlthcare | LAMISIL AT | terbinafine | GEL;TOPICAL | 021958-001 | Jul 24, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription